11-Mar-2024
Download PDF
Wockhardt
A leading European Journal reports a challenging clinical case of successful use of under-trial drug Zidebactum/Cefepime (WCK5222 ZaynichTM) to treat Skull bone infection & Pnuemonia caused by Extreme-drug Resistant Psuedomonas in renal transplant patient.
Ask Value Research 
Informed fund ideas, better judgment. Every month. Mutual Fund Insight, every month since October 2002.
Take charge. Know more. Keep more. Mutual Fund Insight helps you do all three — every month
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.
